EleCeed is the nation’s first precisely-dosed medication that combines equal levels of THC and CBD with a balanced portfolio of secondary cannabinoids delivered in a long-lasting pharmaceutical-quality hard-pressed tablet
The patent-pending pre-scored tablets are now available in 15- and 30-count bottles to patients throughout New York
EleCeed tablets are engineered to address the needs of patients with nervous system diseases such as multiple sclerosis, Parkinson’s disease, epilepsy and neuropathy as well as those suffering from rheumatoid arthritis, Crohn’s disease and chronic pain typically treated with opioids
NEW YORK, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Columbia Care LLC (“Columbia Care”), the nation’s leading medical cannabis company, today announced the introduction of its EleCeed medical cannabis tablets, the first pharmaceutical-quality, hard-pressed tablet that contains a patent-pending formulation of cannabinoids including equal levels of THC and CBD along with 10 additional, precisely formulated secondary cannabinoids. The EleCeed tablets, which contain 10 mg of active cannabinoids, are now available for purchase throughout New York in a new 15-count bottle and a 30-count bottle. Patients can easily split the pre-scored tablets in half, creating additional dosing options.
“We take great pride in our ability to continually innovate and give our patients access to the most cutting-edge medical cannabis products on the market today. EleCeed tablets enable Columbia Care to be the first medical cannabis company in the U.S. to offer patients equal levels of THC and CBD, along with 10 other precisely compounded cannabinoids, to create pharmaceutical-quality, full spectrum hard-pressed tablets. By adding this option to our product portfolio, we can now provide our patients with tablets in a larger range of dose options and give them the duration of relief they need,” said Nicholas Vita, co-founder and chief executive officer of Columbia Care. “To date, Columbia Care has sold over 1 million precisely formulated pills in varying formats to patients in New York. Our desire to create superior products such as these drives our corporate mission of improving patients’ lives through unparalleled research and experience.”
The long-lasting duration of action of the active ingredients in the EleCeed hard-pressed tablets is the result of combining highly crafted agricultural strains, exacting chemistry and precise manufacturing standards with novel drug delivery technologies. This combination will enable patients to reduce the number of required doses per day while simultaneously providing longer symptom relief and reducing cost. In contrast to most currently available liquid-filled capsules that are inconsistent in quality and duration, Columbia Care’s tablets offer a longer duration of action without the risk of leakage or spoilage.
Columbia Care’s patent-pending, 10 mg hard-pressed EleCeed tablets are designed using proprietary, precisely manufactured formulations and delivery technologies. All tablets are imprinted with the Columbia Care logo and product identification, as well as pre-scored to allow for easy splitting. Because of their strength and purity, initially patients will be encouraged to purchase a trial of 15 EleCeed tablets to monitor dose optimization before purchasing a 30-count bottle. The tablets will be available at Columbia Care’s New York dispensaries, including a future location in Brooklyn Heights, and through Columbia Care’s home delivery option. By the end of 2018, Columbia Care plans to make this product available at its dispensaries across the country.
About Columbia Care LLC
Columbia Care is the nation’s largest and most experienced manufacturer and provider of medical cannabis products and services. The Company is licensed in highly selective and regulated jurisdictions and has completed more than 750,000 successful patient interactions since its inception. Working in collaboration with some of the most renowned and innovative teaching hospitals and medical centers in the world, Columbia Care is a patient-centered healthcare company setting the standard for compassion, professionalism, quality, caring and innovation for a rapidly expanding new industry. For more information on Columbia Care, please visit www.col-care.com.
Josephine Belluardo, Ph.D.
LifeSci Public Relations
Released September 19, 2018